Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Abobotulinumtoxin A"'
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Abstract is missing (Quiz)
Externí odkaz:
https://doaj.org/article/cfbc844cb46c472c8dfa24b981e170da
Publikováno v:
JAAD Case Reports, Vol 22, Iss , Pp 93-95 (2022)
Externí odkaz:
https://doaj.org/article/86de4218940e4b028502dbc4ec5c3646
Publikováno v:
Annals of Movement Disorders, Vol 5, Iss 2, Pp 118-120 (2022)
Hemifacial spasm (HFS) is a movement disorder characterized by involuntary twitching of the facial muscles of one side of the face. Here, we report the case of a 31-year-old woman with relapsingremitting multiple sclerosis who presented with left-sid
Externí odkaz:
https://doaj.org/article/90b6deef8e214f728e78d9d2e6c2c5f1
Publikováno v:
Journal de la Faculté de Médecine d'Oran, Vol 3, Iss 1 (2022)
Ankle spasticity in the cerebral palsy walking child: comparative study botulinum toxin A versus rehabilitation. The spastic form of cerebral palsy (PC) is very common,accounting for more than 80% of PC cases. Spasticity leads to muscle contractures
Externí odkaz:
https://doaj.org/article/c337a5d68e614a09967737a93ada4b5e
Publikováno v:
Türk Nöroloji Dergisi, Vol 22, Iss 4, Pp 156-160 (2016)
Objective: Some patients with migraine headache still experience severe migraine attacks despite use of proper prophylactic treatments. There are several treatments for refractory migraine (RM), one of which is abobotulinum toxin A (Dysport). This st
Externí odkaz:
https://doaj.org/article/b2d125276fd645b18fad4281d0c185f5
Publikováno v:
Toxins, Vol 12, Iss 11, p 691 (2020)
Sialorrhea, or excessive saliva beyond the margin of the lip, is a common problem in many neurological diseases. Previously, sialorrhea has been underrecognized in Parkinson’s disease (PD) patients. Despite this, many patients rank sialorrhea as on
Externí odkaz:
https://doaj.org/article/e2cb649c59d14e1cbf06316fd71d9b1c
Autor:
Keith Foster, Matthew Beard
Publikováno v:
Toxins, Vol 12, Iss 2, p 71 (2020)
In contrast to the prevailing arguments presented in the current review, the incidence of neutralising antibody (NAb) formation is not a significant issue for any of the present type A therapeutic botulinum neurotoxin (BoNT) products. Furthermore, cl
Externí odkaz:
https://doaj.org/article/631541b749b34fdfae3fdf96effa111f
Publikováno v:
Toxins, Vol 11, Iss 9, p 510 (2019)
Botulinum neurotoxin A (BoNT/A) appears to be one of the best intravesical treatments for interstitial cystitis/bladder painful syndrome (IC/BPS). We aimed to point out what the evidence is regarding the effects of BoNT/A intravesically injected in p
Externí odkaz:
https://doaj.org/article/8926ff158fd34b00939589b5cf2b0c38
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
George Mitsou, Panagiotis Bouros, Katerina Foska, Irene Nikaina, Antigone S. Papavasiliou, Constantine Filiopoulos
Publikováno v:
Toxins, Vol 5, Iss 3, Pp 524-536 (2013)
This retrospective study aimed to examine the safety of botulinum toxin A (BoNT-A) treatment in a paediatric multidisciplinary cerebral palsy clinic. In a sample of 454 patients who had 1515 BoNT-A sessions, data on adverse events were available in 3
Externí odkaz:
https://doaj.org/article/d00885d80aeb4d9aafd6ba328bd4201e